Keros Therapeutics (KROS) EPS (Basic) (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) EPS (Basic) (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -251.72% |
| Sep 30, 2025 | 76.29% |
| Jun 30, 2025 | -120.65% |
| Mar 31, 2025 | 397.71% |
| Dec 31, 2024 | 12.73% |
| Sep 30, 2024 | -12.38% |
| Jun 30, 2024 | -3.76% |
| Mar 31, 2024 | 11.59% |
| Dec 31, 2023 | -2.80% |
| Sep 30, 2023 | -4.93% |
| Jun 30, 2023 | -0.39% |
| Mar 31, 2023 | -7.19% |
| Dec 31, 2022 | -27.96% |
| Sep 30, 2022 | 18.83% |
| Jun 30, 2022 | -12.45% |
| Mar 31, 2022 | -238.92% |
| Dec 31, 2021 | 65.77% |
| Sep 30, 2021 | -29.61% |
| Jun 30, 2021 | 1.98% |
| Mar 31, 2021 | -9.72% |